The Australian market is experiencing a surge in demand for functional beverages, where chrysanthemum tea has transitioned from a niche ethnic product to a mainstream wellness staple. Australia's clean-label movement drives consumers toward pharmaceutical-grade processing that avoids synthetic sulfur and chemical bleaching.
Due to the diverse climate across Oceania, the stability of botanical active ingredients during transit is a critical pain point. Local distributors require processed mum tea that maintains its volatile oils and antioxidant capacity despite long-haul logistics and varying humidity levels.
Furthermore, the strict regulatory environment imposed by the Therapeutic Goods Administration (TGA) means that "food-grade" is no longer sufficient. There is a growing necessity for "pharmaceutical-grade" slicing and drying techniques to ensure consistent bioavailability in every batch of flower tea.
